Procysbi (cysteamine bitartrate)

pCPA File Number: 21012
Negotiation Status:
Concluded with an LOI
Indication(s):
Nephropathic cystinosis
Sponsor/Manufacturer:
Horizon Therapeutics Ireland DAC
CDA-AMC Project Number:
SR0526-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: